Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Scotiabank Maintains Sector Outperform on Biomea Fusion, Lowers Price Target to $10

Author: Benzinga Newsdesk | August 06, 2025 11:27am
Scotiabank analyst George Farmer maintains Biomea Fusion (NASDAQ:BMEA) with a Sector Outperform and lowers the price target from $30 to $10.

Posted In: BMEA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist